Re: Wall Observer BTC/USD - Bitcoin price movement tracking & discussion
⭐ Merited by infofront (1)
Quote
PFIZER AND BIONTECH ANNOUNCE VACCINE CANDIDATE AGAINST COVID-19 ACHIEVED SUCCESS IN FIRST INTERIM ANALYSIS FROM PHASE 3 STUDY
Monday, November 09, 2020 - 06:45am
Vaccine candidate was found to be more than 90% effective in preventing COVID-19 in participants without evidence of prior SARS-CoV-2 infection in the first interim efficacy analysis
Analysis evaluated 94 confirmed cases of COVID-19 in trial participants
Study enrolled 43,538 participants, with 42% having diverse backgrounds, and no serious safety concerns have been observed; Safety and additional efficacy data continue to be collected
Submission for Emergency Use Authorization (EUA) to the U.S. Food and Drug Administration (FDA) planned for soon after the required safety milestone is achieved, which is currently expected to occur in the third week of November
Clinical trial to continue through to final analysis at 164 confirmed cases in order to collect further data and characterize the vaccine candidate’s performance against other study endpoints
https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-announce-vaccine-candidate-againstMonday, November 09, 2020 - 06:45am
Vaccine candidate was found to be more than 90% effective in preventing COVID-19 in participants without evidence of prior SARS-CoV-2 infection in the first interim efficacy analysis
Analysis evaluated 94 confirmed cases of COVID-19 in trial participants
Study enrolled 43,538 participants, with 42% having diverse backgrounds, and no serious safety concerns have been observed; Safety and additional efficacy data continue to be collected
Submission for Emergency Use Authorization (EUA) to the U.S. Food and Drug Administration (FDA) planned for soon after the required safety milestone is achieved, which is currently expected to occur in the third week of November
Clinical trial to continue through to final analysis at 164 confirmed cases in order to collect further data and characterize the vaccine candidate’s performance against other study endpoints
WOW! Joe Biden has been president since a few hours and he already found a vaccine!
The important bit:
Quote
Based on current projections we expect to produce globally up to 50 million vaccine doses in 2020 and up to 1.3 billion doses in 2021.
Optimism, but still a lot of bumpy road ahead.
Well well, what a shocker. Biden president for not more than a day, and suddenly a Covid-19 "cure" appears out of nowhere.
https://www.cnbc.com/2020/11/08/election-stock-market-futures-open-to-close-news.html
My my, what are the odds? /s
https://www.cnbc.com/2020/11/08/election-stock-market-futures-open-to-close-news.html
My my, what are the odds? /s
The official ratification of the election process and vote by the electoral college takes place on the 14th of December 2020.
At that time Biden will become the President-Elect until the 20th of January 2021, when he will be officially inaugurated and become POTUS.
Perhaps nitpicking I know. With somethings it is good to be accurate as possible imo.
The reality of it is that Trump has no path for re-election at this point. Its over.
-----
What I thought important was this bit.
Quote
'Analysis evaluated 94 confirmed cases of COVID-19 in trial participants
Study enrolled 43,538 participants, with 42% having diverse backgrounds, and no serious safety concerns have been observed; Safety and additional efficacy data continue to be collected'
Study enrolled 43,538 participants, with 42% having diverse backgrounds, and no serious safety concerns have been observed; Safety and additional efficacy data continue to be collected'
Less than 100 cases evaluated...hmmm. And what the hell is a 'diverse background' anyway?
I know personally I will not be trying any experimental vaccine in the near future. Perhaps in a couple of years.